Shikonin suppresses human t lymphocyte activation through inhibition of IKK β activity and JNK phosphorylation

17Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The key role of T cells has been elaborated in mediating immune responses and pathogenesis of human inflammatory and autoimmune conditions. In the current study the effect of shikonin, a compound isolated from a medicinal plant, on inhibition of T-cell activation was firstly examined by using primary human T lymphocytes isolated from buffy coat. Results showed that shikonin dose dependently suppressed T-cell proliferation, IL-2 and IFN-γ secretion, CD69 and CD25 expression, as well as cell cycle arrest activated by costimulation of PMA/ionomycin or OKT-3/CD28 monoclonal antibodies. Moreover, these inhibitory responses mediated by shikonin were found to be associated with suppression of the NF-B signaling pathway via inhibition of the IKKα/β phosphorylation, IB-α phosphorylation and degradation, and NF-B nuclear translocation by directly decreasing IKKβ activity. Moreover, shikonin suppressed JNK phosphorylation in the MAPKs pathway of T cells. In this connection, we conclude that shikonin could suppress T lymphocyte activation through suppressing IKKβ activity and JNK signaling, which suggests that shikonin is valuable for further investigation as a potential immunosuppressive agent. © 2013 Ting Li et al.

Cite

CITATION STYLE

APA

Li, T., Yan, F., Wang, R., Zhou, H., & Liu, L. (2013). Shikonin suppresses human t lymphocyte activation through inhibition of IKK β activity and JNK phosphorylation. Evidence-Based Complementary and Alternative Medicine, 2013. https://doi.org/10.1155/2013/379536

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free